user avatar
Nitin Jain
@NitinJainMD
Professor, Dept of Leukemia, MD Anderson Cancer Center | Director, CAR-T Leukemia Program | #CLL #ALL #TcellRx | via @aiims_newdelhi | Tweets: my own opinions
Houston, Texas
faculty.mdanderson.org/Nitin_Jain/Def…
Joined August 2014
733
Following
10K
Followers
Posts
  • user avatar
    Nitin Jain
    @NitinJainMD
    Sep 1, 2023
    👉👉Super delighted to share that I have been promoted to Professor of Medicine, Department of Leukemia at MDACC My journey AIIMS->MCW->MDACC->MSKCC->UofC->MDACC MDACC has been my home since 2012 #hope #endcancer Heartfelt THANKS to all who have guided me through the yrs
    69K
  • user avatar
    Nitin Jain
    @NitinJainMD
    May 4, 2022
    👉👉Super excited to share that I received this year’s Leukemia & Lymphoma Society (LLS) Career Development Award A huge THANKS to Drs Kantarjian, Konopleva, Wierda, Gandhi, Mesa, Stock and many others 🙏🏽🙏🏽 @MDAndersonNews @LLSusa #leusm
  • user avatar
    Nitin Jain
    @NitinJainMD
    May 27, 2022
    LIFE HISTORY of Investigator-initiated (sponsored) trial (IIT / IST) A🧵 Day 1. An idea. It came to you. Or came to your mentor. You saw something somewhere. Maybe it was @Ash or @ASCO. You connected the dots. Month 1. You discuss it with your group. 1/19
  • user avatar
    Nitin Jain
    @NitinJainMD
    Oct 27, 2022
    👉👉👉 Excited to share results of nivolumab + ibrutinib in patients with Richter Transformation | Published today in @BloodAdvances -24 pts DLBCL RT -Median prior Rx for CLL/RT = 3 -10/24 (42%) had a response (64% BTKi-naive; 23% BTKi-exposed) -Median DOR 15 mos #CLL #lymsm
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jan 22, 2023
    MD Anderson Cancer Center on a quiet Sunday morning @MDAndersonNews #WeekendRounds #Hope #EndCancer
    18K
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jul 25, 2024
    👉👉👉Delighted to share review article on #CLL (with my colleagues Drs Bill Wierda and Susan O’Brien) published in the Journal Lancet today!! @TheLancet @wwierda @MDAndersonNews @DrHKantarjian Chronic lymphocytic leukaemia - The Lancet thelancet.com/journals/lance…
    19K
  • user avatar
    Nitin Jain
    @NitinJainMD
    Oct 16, 2021
    Axi-cel Brex-cel Brex-cel Yescarta Tecartus Tecartus DLBCL/FL MCL B-ALL Flu 30x3 Flu 30x3 Flu 25x3 Cy 500x3 Cy 500x3 Cy 900x1 2M/kg 2M/kg 1M/kg #CART #TCELL #tcellRx #ALL
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jul 25, 2023
    Super cheers to our super 🌟 Leukemia fellow Dr Senapati @jayastuMD who is completing Leukemia fellowship and will join us as Faculty in the Department of Leukemia 👏👏🎊🎉@MDAndersonNews Wishing you all the BEST!! WELCOME!! Super proud @DrHKantarjian @garciamanero @TapKadia
    34K
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jan 29, 2022
    👉👉I found this table derived from @NCCN #CML guidelines to be extremely helpful in TKI selection based on ABL1 kinase domain mutations (I used it recently to select TKI for a patient with relapsed CML in myeloid blast crisis) #leusm @DrHKantarjian @GCC_Cortes
  • user avatar
    Nitin Jain
    @NitinJainMD
    Mar 28, 2023
    Something to be said about garam chai in the morning before going to work!
    16K
  • user avatar
    Nitin Jain
    @NitinJainMD
    Feb 26, 2022
    👉👉It looks like we will have 2 different classifications for Hem Malignancies!! Very interesting read about history of WHO Classification. A new International Consensus Classification of Myeloid and Lymphoid Neoplasms (ICC-MLN) vs WHO Classification
    onlinelibrary.wiley.com
    Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international...
    Click on the article title to read more.
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jun 13, 2023
    Looking forward to visiting family and friends in India! 🇮🇳 (Pic of immigration hall in Delhi- a familiar place to many of us coming to India) #HomeSweetHome #LoveIndia
    10K
  • user avatar
    Nitin Jain
    @NitinJainMD
    Nov 5, 2022
    👉👉👉Celebrating 1000th cell therapy infusion at @MDAndersonNews A great team effort led by Drs EJ Shpall and Sattva Neelapu Quoting Dr Neelapu ‘We are curing patients and we are making Cancer History’ 👏👏🙏🏽🙏🏽 @EJShpallMD @ppisters #CARTOX #CAR-T #TcellRx
  • user avatar
    Nitin Jain
    @NitinJainMD
    Jun 8, 2022
    👉👉 Thrilled to receive second LLS award this year. This is Translational Research Program (TRP) award to target LCK in T-cell ALL. Clinical trial (IST) with ponatinib activated today. @MDAndersonNews Collaboration with Dr Konopleva and @Junjyang of @StJude 🙏🏽🙏🏽 @LLSusa